Advancing HIV, HCV, STIs, LGBTQ health, and drug user health
 
HealthHIV Logo Putting Health First

Florida AIDS Drug Assistance Program

May 29, 2026

Florida State Legislature Adopts FY2026-27 Budget Protecting Decades Old AIDS Drug Assistance Program

Today the Florida State Legislature adopted its FY2026-27 Budget that protects the decades old AIDS Drug Assistance Program.

ADAP Eligibility is protected at 400% FPL
$75 million is appropriated from the Grants and Donations Trust in FY2025-26 and authorizing the carry over of those funds into FY 2026-27.

ADAP Formulary is fully restored upon the signature of the Florida Governor, therefore the formulary can be restored prior to the upcoming fiscal year beginning on July 1
OPPAGA, the Florida State Legislature’s research arm will provide greater accountability/transparency and a full evaluation and review of Florida’s ADAP where the Florida Dept of Health “shall” assist in that review: https://oppaga.fl.gov/

ADAP will continue to assist with prescription co-payments, but it will not provide premium assistance.

Leaves potential opportunity to possibly restore Premium Assistance in the next fiscal year as the prohibition on premium assistance in the short-gap measure was removed.


April 16, 2026

CURRENT SITUATION: While the Florida Legislature approved approximately $31 million in House-directed bridge funding through HB 697 to stabilize Florida’s AIDS Drug Assistance Program (ADAP) through June 30, it represents only a temporary and incomplete restoration.

Local community-based organizations are picking up insurance premium payments for some clients—roughly doubling what they were previously doing—which requires taking money away from other Ryan White Part B services, making it a “zero-sum” game for many Floridians living with HIV. Even though some individuals are able to maintain insurance coverage as a result, these workarounds are depleting other available HIV treatment services. 

The legislation restored stop-gap eligibility to 400% of the federal poverty level (FPL) but did not reinstate insurance premium assistance and shifted the program toward direct medication distribution, leaving gaps in access to certain regimens. 

For reference, the FPL for a household of one in the U.S.is:$15,060 per year

  • 130% FPL: ~$19,578
  • 400% FPL: ~$60,240

With the funding set to expire at the end of the fiscal year and a broader structural deficit still unresolved, upcoming legislative action will be critical, particularly as concerns remain about additional formulary restrictions if longer-term solutions are not reached.

OF SPECIAL NOTE: The state did not renew multiple contracts with the AIDS Healthcare Foundation (AHF), cutting off $3.5 million in state funding for services including HIV testing, treatment, housing, and care navigation. This removes established providers from the system and leaves people relying on those services without clear pathways to care. AHF has stated that it believes contracts were not renewed in retaliation for legal challenges and public advocacy against the ADAP cuts.

FLORIDA RESOURCES:

Florida Senate Proposes ADAP Bridge Funding Through June 30

March 10, 2026

Florida Senate Proposes ADAP Bridge Funding Through June 30

On March 10, the Florida Senate leadership introduced an amendment to House Bill 697 providing $30.9 million in short-term bridge funding to continue the state’s AIDS Drug Assistance Program (ADAP) through June 30, 2026. The amendment temporarily restores program eligibility up to 400% of the federal poverty level. 

During the bridge period, most participants would receive HIV medications through a direct-dispense distribution system administered by county health departments. The program would use the ADAP formulary in effect as of March 1, 2026, which removes Biktarvy from the direct-dispense program and restricts Descovy, while other clinically equivalent treatment options remain available. Self-insured clients would continue receiving copay assistance and retain access to the broader formulary.

The amendment is intended to stabilize medication access following earlier ADAP rule changes tied to a projected $120 million funding shortfall. That gap has been attributed to rising insurance costs and the expiration of enhanced ACA premium tax credits.

The proposal also requires the Florida Department of Health to submit monthly public reports beginning April 1 detailing program revenues, expenditures, enrollment, prescription utilization, and fiscal sustainability. These reports are intended to inform lawmakers as they negotiate longer-term funding and policy decisions, including the Senate’s proposed $118.3 million ADAP funding level for FY 2026–2027, during the upcoming budget conference process. Any final appropriations are subject to conference negotiations and the Governor’s line-item veto.

Florida ADAP March 5 Forum Summary

March 5, 2026

ViiV Healthcare’s Patient Assistance Program

Enrollment information and more is available for providers and people with HIV  online or by calling ViiV Connect directly at:   844-588-3288. 

Emergency 30-day Supply Available Via a Presumptive Fill Process 

  • There is an option for a 30-day emergency supply of a medication by providers requesting a presumptive fill. Patients can have three presumptive fills in a lifetime. 
  • There is a 24/7 presumptive fill portal (including weekends). Provider verified by ID.me. Once approved – can fill the prescription at a pharmacy. Still building the pharmacy network for the program. Pharmacies can join by signing an agreement with PDMI.
  • More information is available on www.viiv.connect.com by searching for “presumptive” or go to  https://www.viivconnect.com/hcp/orals/ and scroll down to ”request immediate access to an oral medication for your patient” which will take you to the presumptive fill portal.

Patient Assistance Program Process

  • To avoid processing delays, ensure that all of the questions on the form are completed. This includes a signature from the health care professional and patient.  HCP needs to print the form for the patient to sign and then fax it in with the prescription. ViiVConnect does not accept electronic prescriptions except from New York.
  • Enrollment typically takes 24 to 48 hours to process if there’s no missing information in the form. Drug ships within 4 to 6 days. Cabenuva is shipped overnight.
  • A denial letter from ADAP is not required and ViiV staff have been advised of this.
  • ViiV plans on keeping eligibility at the 500% FPL level but are continuously evaluating the program.
  • Important for the patient to indicate their preferred method of communication so that they receive communications and updates on the application’s status.
  • ViiV’s patient assistance program provides medications by mail order only.
  • If request is for Cabenuva – need to designate location for the injectable. Option to indicate if requires an oral lead. Oral lead in ships directly to the patient. ViiV does not cover cost of administering the injectable.
  • Enrollment extends for a year, but ViiV conducts periodic eligibility checks
  • Health care professionals receive a confirmation via fax of enrollment status. Patient also receives notification if indicated a preferred method of communication.

Other Q&A:

  • Does ViiV have a copay program?  Yes – copay assistance is available  for ViiV medications.  More information is available from the ViiV Connect oral medication page and injectables page. 
  • Will ViiV support clients who have family planning Medicaid?  As of today – people with family planning Medicaid are not an approved population, but ViiV is working on the issue as well as for people with emergency Medicaid coverage. 

ACA Marketplace Special Enrollment Period for ADAP Clients  

See:  The AIDS Institute’s Fact Sheet:  Options for Florida ADAP Enrollees When ADAP Premium Assistance Stops

  • The Florida ADAP program stopped paying the premiums for ACA coverage for ADAP clients on March 1 but did not cancel their coverage. 
  • Around 80% of ADAP clients are eligible for advanced premium tax credits so the state was only paying for part of their monthly premium. 
  • The advanced premium tax credits will continue for those who were eligible so most clients will not be responsible for the full premium amount. 
  • ACA requires insurers to provide a grace period.
  • For people receiving advanced premium tax credits – there is a 90-day grace period before insurance is cancelled.  During the first month (March) of non-payment by ADAP  – client access to providers and ability to fill medications should continue. In the second and third months (April and May) – the insurer will no longer pays claims and will put them in pending status. Clients will have until the end of May to pay back the premiums. If clients do not pay back premiums or change plans by the end of May then their insurance will be cancelled with a termination date of April 1. After March, prescriptions will be denied. 
  • For clients without advanced premium tax credits – the grace period is determined by state law but is typically 31 days.  

Special Enrollment Period

  • The Centers for Medicare and Medicaid Services created a special enrollment period for Florida ADAP clients. ADAP clients can change their plan and apply for advanced premium tax credits until April 30.
  • Clients can evaluate plan options from healthcare.gov. Important for clients to not just evaluate based on premium costs – but to also check the drug formulary and out of pocket costs for medications in addition to ensuring their providers are in network.
  • Clients should be cautious of catastrophic coverage plans and high-deductible plans. 
  • Clients may want to stick with one of the ADAP approved plans in the event ADAP premium assistance is restored. 
  • Clients who rushed to change their ACA plan right after the cuts were announced also can use the special enrollment period to re-evaluate their options and change their plan.
  • ACA enrollment staff should be aware of the special enrollment period. If they are not aware — ask to talk to a supervisor.  
  • Clients will need proof of insurance termination for the special enrollment period. Clients can use their ADAP termination letter.  
  • The special enrollment period – is only available to people who are eligible for ACA coverage.
  • When clients enroll in a new plan – the coverage will start on the first of the month after enrollment is complete. Clients can ask for coverage to start retroactively back to March 1. 
  • Advise for clients to take advantage of the special enrollment and take some time to shop online for an affordable plan that meets their needs. Clients should be on alert for junk plans that may have lower premiums but will be more costly in the end because they will not adequately cover medications or health care services. 
  • Clients with income under 200% FPL should consider a silver plan because they come with extra benefits for people with income under 200% FPL.
  • Cost sharing assistance is still available from ADAP for people with commercial insurance and Medicare up to 400% FPL. It was reported during the meeting that ADAP may be covering cost sharing for Biktarvy for clients with Medicare or commercial insurance coverage (including for those enrolled in ACA plans). Also reported that prior authorization for Descovy may be delayed until April. 

Advocacy Update       

  • Still advocating in the legislature for a reversal of the cuts and there is support from both chambers. 
  • Upcoming court dates:
  • On March 11 – there will be a circuit court hearing regarding the injunction filed by AHF. 

On March 17 – there will be an administrative law court hearing challenging the emergency rule that will likely be accessible via zoom. 

On your time. In your space.

HealthHIV

1630 Connecticut Ave. NW
Suite 500
Washington, DC 20009

202-232-6749
[email protected]

Connect

Get the latest training opportunities, news, and more delivered directly to your inbox.

Get Updates
 

© Copyright 2026 HealthHIV. All rights reserved. | Privacy Policy | Site Map | About
HealthHIV is a 501(c)(3) organization. Donations are tax-deductible to the extent permitted by law. EIN: 52-2253960